Cargando…
Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
Autores principales: | McAnally, Heath B., Bonnet, Udo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119509/ https://www.ncbi.nlm.nih.gov/pubmed/33565040 http://dx.doi.org/10.1007/s40122-020-00224-x |
Ejemplares similares
-
Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
por: McAnally, Heath, et al.
Publicado: (2020) -
Correction to: Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
por: McAnally, Heath, et al.
Publicado: (2020) -
Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
por: Peckham, Alyssa M., et al.
Publicado: (2021) -
Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
por: Bonnet, Udo, et al.
Publicado: (2021) -
Rationale for and approach to preoperative opioid weaning: a preoperative optimization protocol
por: McAnally, Heath
Publicado: (2017)